Baba Ramdev’s company Patanjali Ayurved’s product will not be able to sell its immunity booster product as the ‘Coronil’ tablet anymore after the Madras High Court made absolute an interim injunction passed last month.
In a report by bar and bench While the company has been marketing this tablet as a cure for the Coronavirus, the HC said Patanjali is merely “chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the Coronavirus, when actually their ‘Coronil Tablet’ is not a cure but rather an immunity booster for cough, cold and fever”.
The name ‘Coronil’ is an infringement on a trademarked registered by Chennai-based Arudra Engineering Private Limited, for ‘CORONIL-92 B’ as an Acid inhibitor product for industrial cleaning and chemical preparations for industrial use in June 1993. The defendants, Patanjali and Divya Yog Mandir Trust were not able to show due cause for using this name as the tablet has no connection to the Coronavirus, and further, they had merely applied for registration of the name and it was still in the initial stages of registration.
The court noted that there are organizations that are helping people during this critical period without seeking recognition and directed the defendants to pay Rs 5 lakhs each towards the Adyar Cancer Institute and the Government Yoga and Naturopathy Medical College and Hospital, Arumbakkam.
In the first week of July, Yoga Guru Baba Ramdev had launched an Ayurveda medicine for Corona Virus called “Coronil” claiming huge success with the clinical trials. After the public launch of an alleged claim for Covid-19, Pathanjali Ayurveda’s marketing stunt with ‘Coronil’ has effectively backfired. The claims made by Pathanjali were publicized prematurely and with no clinical data to prove that they are safe and effective.